Why I’d ditch this falling knife to buy this small-cap growth stock

Royston Wild discusses two stocks with very different investment profiles.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Velocys (LSE: VLS) has taken another pasting in Friday business after a less-than-welcome reception to latest trading details, the stock last 18% lower on the day and erasing all of the hard-won gains of recent weeks.

The renewable fuel specialist advised that revenues more than halved during the six months to June, to £234,000 from £509,000 in the same 2016 period. And pre-tax losses ballooned to £10.6m versus £7.7m previously.

Velocys was whacked in large part by the impact of sterling’s slide over the past year, and it advised that it “incurs much of its expense in US dollars and has exposure to the US dollar exchange rate.” As a result the firm suffered an exchange-rate-related hit to the tune of £900,000.

Release fuels investor fears

As well as being prepared for further currency-related woes down the road, investors are also worried about funding issues over at the Oxford business.

It tapped shareholders for £10m in May “to fund the pre-FEED (FEL-2) engineering study for the first biorefinery, to undertake a joint technology demonstration with our partner TRI, and to extend Velocys’ loan arrangement with ENVIA to support the plant in achieving steady state operations.” However, Velocys has advised that it will require additional funding to get its bio-refinery in the US up and running.

The City had already been expecting Velocys to chalk up losses before tax of £14.4m in 2017, but this forecast is likely to receive a hefty downgrade in the wake of today’s release.

And the very real possibility that the pound could continue to struggle, and more operational issues transpire that could whack revenue growth, may also cause the estimated loss of £6.8m pencilled in for 2018 miss to the downside.

In my opinion there is still far too much uncertainty circulating around Velocys right now, and as a result I for one won’t be investing.

Strap in and make a mint

Instead, I would much rather throw my hard-earned cash at industrial bolt and fastenings specialist Trifast (LSE: TRI).

Thanks to the hard work the Uckfield business has put into developing relationships with blue chip OEMs across the globe, and the strength of key sectors like automotive, industrials and electronics, the company continues to enjoy resplendent organic revenues growth in its territories. And Trifast is giving the top line an extra boost through its ambitious M&A strategy — it identified two targets in the first half but withdrew interest “due to their lack of strategic future-proofing” — and the vast sums it is investing in its existing operations.

In its latest trading statement the business advised last week that “our visibility and order pipeline remains very encouraging, whilst our balance sheet is strong,” and this encourages me that the firm can meet sprightly broker projections. Current estimates speak of a 20% earnings boost in the 12 months to March 2017, and an extra 3% rise for 2018.

I reckon Trifast is a great share pick right now given its robust sales momentum and successful self-help programme, not to mention its undemanding prospective earnings multiple of 16.3 times.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »